Ascletis Pharma Inc Ordinary Shares 01672
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 1.31
- Day Range
- HKD 1.31–1.34
- 52-Week Range
- HKD 1.21–2.87
- Bid/Ask
- HKD 1.31 / HKD 1.33
- Market Cap
- HKD 1.34 Bil
- Volume/Avg
- 92,000 / 909,798
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 22.47
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 6.59%
Company Profile
Ascletis Pharma Inc is an investment holding company engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. ritonavir tablets, GANOVO, and ASCLEVIR. Geographically, it operates in Mainland China and other countries.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 219
- Website
- https://www.ascletis.com
Comparables
Valuation
|
Metric
|
01672
|
01167
|
02877
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 6.53 |
Price/Book Value | 0.53 | 1.35 | 0.91 |
Price/Sales | 22.47 | 19.02 | 1.39 |
Price/Cash Flow | — | — | 6.14 |
Price/Earnings
01672
01167
02877
Financial Strength
|
Metric
|
01672
|
01167
|
02877
|
|---|---|---|---|
Quick Ratio | 16.51 | 5.67 | 2.97 |
Current Ratio | 16.58 | 5.70 | 3.35 |
Interest Coverage | −1,693.40 | −47.87 | 419.36 |
Quick Ratio
01672
01167
02877
Profitability
|
Metric
|
01672
|
01167
|
02877
|
|---|---|---|---|
Return on Assets (Normalized) | −5.34% | −22.98% | 10.83% |
Return on Equity (Normalized) | −5.59% | −33.40% | 13.16% |
Return on Invested Capital (Normalized) | −9.56% | −28.24% | 12.66% |
Return on Assets
01672
01167
02877
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Kxnmvrsf | Mhlv | $566.6 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Bzkzrjjkk | Hfgzg | $102.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Pxxzncd | Cqldwq | $97.3 Bil | |
MRNA
| Moderna Inc | Rkddxpy | Wrj | $42.7 Bil | |
ARGX
| argenx SE ADR | Wdyylvkt | Hwhhg | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Ymgvthchy | Kyttw | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Kwtrgfnr | Shnld | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Tvynbqy | Mzlxkv | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Rcgpmkzstq | Xwdsnl | $12.6 Bil | |
INCY
| Incyte Corp | Ncxkwdbh | Sndzyz | $11.8 Bil |